Kylie McLaughlin

Associate Principal Scientist at CV6 Therapeutics, (NI) Ltd.
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Belfast, Northern Ireland, United Kingdom, UK

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Credentials

  • Fellow of Institute of Biomedical Science
    Institute of Biomedical Science
    Feb, 2017
    - Nov, 2024

Experience

    • United Kingdom
    • Pharmaceutical Manufacturing
    • 1 - 100 Employee
    • Associate Principal Scientist
      • Nov 2022 - Present

    • Drug Development Senior Scientist
      • Jul 2015 - Nov 2022

    • United Kingdom
    • Higher Education
    • 700 & Above Employee
    • Visiting Scholar
      • Jul 2015 - Present

    • Research Assistant
      • May 2015 - Jul 2015

    • Research PhD Student
      • Sep 2011 - Jul 2015

      As a member of Patrick Johnston’s drug resistance group and Kevin Prise’s radiation biology group at the Patrick Johnston Centre for Cancer Research I completed my doctoral research on the role of FLIP as a novel regulator of resistance to ionising radiation.

    • Laboratory Demonstrator
      • Sep 2012 - Jan 2013

      Demonstration and teaching of laboratory molecular biology techniques for School of Biological Sciences undergraduate year 2 module - Molecular Genetics.

    • Teaching Assistant
      • Sep 2011 - Jun 2012

      Teaching assistance for 2 modules as part of undergraduate medical program. "Cell, Tissues & Organs: Foundations of Clinical Practice I and II"

    • Sweden
    • Higher Education
    • 700 & Above Employee
    • Visiting Researcher
      • Jul 2011 - Sep 2011

      Bertrand Joseph lab @ Cancer centrum Bertrand Joseph lab @ Cancer centrum

    • United Kingdom
    • Higher Education
    • 700 & Above Employee
    • Summer Research Student
      • Jul 2010 - Aug 2010

      Within the drug resistance group I worked with HDAC inhibitors and chemotherapy in colorectal cancer models. Contributed to publication: Kerr, E. et al. Identification of an acetylation-dependant Ku70/FLIP complex that regulates FLIP expression and HDAC inhibitor-induced apoptosis. Cell Death and Differentiation 1–11 (2012). doi:10.1038/cdd.2012.8 Within the drug resistance group I worked with HDAC inhibitors and chemotherapy in colorectal cancer models. Contributed to publication: Kerr, E. et al. Identification of an acetylation-dependant Ku70/FLIP complex that regulates FLIP expression and HDAC inhibitor-induced apoptosis. Cell Death and Differentiation 1–11 (2012). doi:10.1038/cdd.2012.8

Education

  • Queen's University Belfast
    Doctor of Philosophy (PhD), Medicine (Oncology)
    2011 - 2015
  • Queen's University Belfast
    Biomedical Science, Biomedical Sciences, General
    2008 - 2011
  • University of South Wales
    Foundation Degree in Applied Sciences, Pre-Chiropractic Studies
    2003 - 2004

Community

You need to have a working account to view this content. Click here to join now